London Regional Cancer Program
Alison Allan has not added Biography.
If you are Alison Allan and would like to personalize this page please email our Author Liaison for assistance.
Beta(3) integrin expression increases breast carcinoma cell responsiveness to the malignancy-enhancing effects of osteopontin.
Molecular cancer research : MCR Sep, 2003 | Pubmed ID: 14517343
Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry.
Cytometry. Part A : the journal of the International Society for Analytical Cytology May, 2005 | Pubmed ID: 15810015
A new model for lymphatic metastasis: development of a variant of the MDA-MB-468 human breast cancer cell line that aggressively metastasizes to lymph nodes.
Clinical & experimental metastasis , 2005 | Pubmed ID: 16170671
Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer.
The American journal of pathology Jul, 2006 | Pubmed ID: 16816376
Tumor dormancy and the role of metastasis suppressor genes in regulating ectopic growth.
Future oncology (London, England) Oct, 2006 | Pubmed ID: 17026454
Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis.
Breast disease , 2006-2007 | Pubmed ID: 17473368
Osteopontin overexpression in breast cancer: knowledge gained and possible implications for clinical management.
Journal of cellular biochemistry Nov, 2007 | Pubmed ID: 17721886
The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanisms.
Breast cancer research and treatment Nov, 2008 | Pubmed ID: 18097747
Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1.
International journal of cancer. Journal international du cancer Aug, 2008 | Pubmed ID: 18470911
High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.
Journal of cellular and molecular medicine Aug, 2009 | Pubmed ID: 18681906
Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer.
Cytometry. Part B, Clinical cytometry Mar, 2009 | Pubmed ID: 18727054
New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target?
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica Jul-Aug, 2008 | Pubmed ID: 18834402
Characterization of tumor cell dissemination patterns in preclinical models of cancer metastasis using flow cytometry and laser scanning cytometry.
Cytometry. Part A : the journal of the International Society for Analytical Cytology Apr, 2009 | Pubmed ID: 18855920
Lymphatic metastasis of breast cancer cells is associated with differential gene expression profiles that predict cancer stem cell-like properties and the ability to survive, establish and grow in a foreign environment.
International journal of oncology Aug, 2009 | Pubmed ID: 19578743
Circulating tumor cell analysis: technical and statistical considerations for application to the clinic.
Journal of oncology , 2010 | Pubmed ID: 20049168
The role of human aldehyde dehydrogenase in normal and cancer stem cells.
Stem cell reviews Jun, 2011 | Pubmed ID: 21103958
Deletion of the thrombin cleavage domain of osteopontin mediates breast cancer cell adhesion, proteolytic activity, tumorgenicity, and metastasis.
BMC cancer , 2011 | Pubmed ID: 21247495
Migratory strategies of normal and malignant stem cells.
Methods in molecular biology (Clifton, N.J.) , 2011 | Pubmed ID: 21618081
Notch1 inhibition alters the CD44hi/CD24lo population and reduces the formation of brain metastases from breast cancer.
Molecular cancer research : MCR Jul, 2011 | Pubmed ID: 21665937
Image cytometry analysis of circulating tumor cells.
Methods in cell biology , 2011 | Pubmed ID: 21704842
The role of erythropoietin and erythropoiesis-stimulating agents in tumor progression.
Clinical cancer research : an official journal of the American Association for Cancer Research Oct, 2011 | Pubmed ID: 21750199
Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44⁺ human breast cancer cells.
Breast cancer research and treatment May, 2012 | Pubmed ID: 21818590
Recombinant human erythropoietin in combination with chemotherapy increases breast cancer metastasis in preclinical mouse models.
Clinical cancer research : an official journal of the American Association for Cancer Research Oct, 2011 | Pubmed ID: 21856770
Detection of circulating tumor cells in advanced head and neck cancer using the CellSearch system.
Head & neck Oct, 2012 | Pubmed ID: 22076949
The Role of Cancer Stem Cells in the Organ Tropism of Breast Cancer Metastasis: A Mechanistic Balance between the "Seed" and the "Soil"?
International journal of breast cancer , 2012 | Pubmed ID: 22295241
Circulating tumour cells in prostate cancer patients receiving salvage radiotherapy.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico Feb, 2012 | Pubmed ID: 22301405
User-defined protein marker assay development for characterization of circulating tumor cells using the CellSearch® system.
Cytometry. Part A : the journal of the International Society for Analytical Cytology Nov, 2012 | Pubmed ID: 22899576
Response to Rossi et al.
Cytometry. Part A : the journal of the International Society for Analytical Cytology Jul, 2013 | Pubmed ID: 23788417
Recent advances in the molecular characterization of circulating tumor cells.
Cancers , 2014 | Pubmed ID: 24633084
Lung-derived factors mediate breast cancer cell migration through CD44 receptor-ligand interactions in a novel ex vivo system for analysis of organ-specific soluble proteins.
Neoplasia (New York, N.Y.) Feb, 2014 | Pubmed ID: 24709425
Nanoparticle-mediated binning and profiling of heterogeneous circulating tumor cell subpopulations.
Angewandte Chemie (International ed. in English) Jan, 2015 | Pubmed ID: 25377874
Why does breast cancer often spread to the lung?
Women's health (London, England) Nov, 2014 | Pubmed ID: 25482482
Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors.
Clinical & experimental metastasis Jan, 2016 | Pubmed ID: 26445849
Central, But Not Peripheral, Circulating Tumor Cells are Prognostic in Patients Undergoing Resection of Colorectal Cancer Liver Metastases.
Annals of surgical oncology Jul, 2016 | Pubmed ID: 26714949
Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer.
Breast cancer research and treatment May, 2016 | Pubmed ID: 27116183
Matthew M. Piaseczny*,1,2,
Graciella M. Pio*,1,2,
Jenny E. Chu1,2,
Ying Xia1,
Kim Nguyen1,3,
David Goodale1,
Alison Allan1,2,4,5
1London Regional Cancer Program, London Health Sciences Centre,
2Department of Anatomy & Cell Biology, Schulich School of Medicine & Dentistry, Western University,
3Department of Biochemistry, Schulich School of Medicine & Dentistry, Western University,
4Department of Oncology, Schulich School of Medicine & Dentistry, Western University,
5, Lawson Health Research Institute
Copyright © 2024 MyJoVE Corporation. 판권 소유